Followers | 36 |
Posts | 2,689 |
Boards Moderated | 0 |
Alias Born | 06/09/2011 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes that too and hopefully soon!!
I agree with you 100% on this post!
I would think by now NWBO's investigation with Charles Price and Cofer Black, CIA with resources available to them across government agencies I expect they have accumulated tremendous research on this topic and are getting closer to completing their investigation. JMHO
Press Release
08
DEC
2015
NW Bio Statement Regarding Appointments
BETHESDA, MD, December 8, 2015 – Northwest Biotherapeutics (NASDAQ: NWBO) (“NW Bio”), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, responded today to shareholder questions about appointments relating to the Company’s Board, and an independent investigation of recent allegations in an anonymous internet report and a derivative lawsuit which cites the anonymous internet report.
I hope you are right Flip! We all have seen the Linda Liau presentation last week in Seattle and slides supporting the potential for favorable efficacy for DCVax-L.
Management has to come through with some positive news! We knew financing had to be soon and I did not go back and check but was this the financing held up on the 20% rule?
Maverick has posted Charden Capital was getting involved with NWBO as noted in this PR.
Mr. Maza, where is any communication with shareholders? Are the doors still open? Lights on?
Brain tissue banking for stem cells for our future.....cites DCVax in quote at bottom.
Emily Palmero, Sheryl Palmero & Wayne Murrell
Scientific Reports 6, Article number: 39394 (2016)
doi:10.1038/srep39394
Download Citation
Cancer stem cellsPreclinical research
Received:
04 August 2016
Accepted:
23 November 2016
Published online:
19 December 2016
http://www.nature.com/articles/srep39394
Nice article and fair, balanced with nice headline!
Thanks for sharing TC!
Not from what I see as this is from the link below?
Sponsors and Collaborators
Northwest Biotherapeutics
Investigators
Principal Investigator: Linda Liau, M.D. University of California, Los Angeles
Study Director: Marnix L. Bosch, MBA, PhD Northwest Biotherapeutics
The shorts are pulling out all the stops now and are going all out on NWBO!
After Woodford takes a bath on NW Bio, British investor decides to towel off
by Ben Adams | Dec 12, 2016 4:34am
http://www.fiercebiotech.com/biotech/after-woodford-takes-a-bath-nw-bio-british-investor-decides-to-towel-off
This has been posted before but this abstract from Dr. Liau, Dr. Prins of UCLA and Dr. Bosch from Northwest Bio is a reminder of the results we can expect from our international Phase III GBM trial! (Link at Bottom)
Interesting Horizon's Phase III FA trial has failed. Where is update with Shire/ILNS Phase I trial result?
http://www.fiercebiotech.com/biotech/horizon-slumps-after-phase-3-friedreich-s-ataxia-trial-flops?utm_medium=nl&utm_source=internal&mrkid=644672&mkt_tok=eyJpIjoiWmpKalpqZzFOekk0TXpabSIsInQiOiIyWEtvbDZxVkNSYW9EdEd4Y2lKSGVseENnRWc0S0JtajNSUnV5K1FsTE8xNGF4XC9YVUE5S3FVSlVKMWU1UFRVcndmYVAxN3VlTUN4djBibkRcL0JIZ294ekVkUjQ0aVByQndBWU5ZcEY1a0h3PSJ9
I agree with this view and wanted to add to it that regulators granting DCVax -L approval in EU, US & Canada for GBM and other types of brain cancers would ensure that manufacturing capacity has to meet demand, certified, tested by regulators and ready when the approval is publicly granted. You would have tens of thousands of patients lining up for the vaccine after an approval and if production was not ready to meet the demand you would have failure at all levels.
The Sawston purchase and build out, 32k square foot expansion at Cognate, expansion at Fraunhofer as well as King's $2m build out in UK all happening around or after the partial screening hold of new patients is a telling sign in my opinion. This is the most important part in obtaining regulatory approval because if you cannot effectively produce the vaccine to meet demand it would be a major failure. Many here on this IHUB board have researched this information via their due diligence otherwise we would not have heard much about it as well.
We will find out in the very near future as this international Phase III trial is reaching its primary endpoint. GLTA Longs!
NWBO is moving up nicely on volume hitting ASK and looking green soon!
notbrad, I agree and was my thought on this as well as LP had stated she wanted the trail to go to completion. NWBO likes to provide key words in PR's and below in bold and underlined I believe in just another hint that regulators did not want patients continuing into randomization in the Phase III trial as LP stated "turning good news into bad".
From yesterday's PR
Northwest Biotherapeutics Inc (NASDAQ:NWBO) shares were up 4.33% on Wednesday to $0.547 but could give up its gains when it returns to the OTC Markets.
http://smallcapexclusive.com/delisting-underway-northwest-biotherapeutics-inc-nasdaqnwbo-shares/
This follows Northwest Biotherapeutics Inc receiving a letter from the Nasdaq Staff on November 7, 2016 indicating that they determined to aggregate a series of financing transactions that were completed between May 15, 2016 and October 13, 2016, although the transactions were in many cases small and diverse, and involved a number of unrelated parties. The company engaged in remediation discussions with the Nasdaq Staff who ultimately determined not to accept the Company’s proposed plan of remediation.
Yes you can clearly see how NWBO has been focused on manufacturing efficiency and costs as far back as 2012/13 as I remember conversation with Les a few years ago acknowledging that number on the $37k per year and $111k for 3 year supply for each patients DCVax.
Great post Flip and agree with you on the pricing as Linda has mentioned a couple of times a while back the annual cost of DCVax at $37k per year or $111k for 3 year manufacturing of each patients vaccine of DCVax!
Great post iwasadiver! I agree with you 100% on both LP and Mr. Black.
GLTA!
Very well stated Doc!!
1000. The method of PEI coordinates - Voluntary Harmonisation Procedure (VHP) clinical trials.
My comment: This 60 days approval for clinical trial is a good sign for Direct/Ketruda Phase II trial for colorectal cancer beginning enrollment soon, IMHO.
http://www.pei.de/DE/infos/presse/pressemitteilungen/2016/19-1000-vhp-verfahren-vom-pei-koordiniert-freiwilliges-harmonisierungsverfahren-klinischer-pruefungen.html
Great post Flip!! The Slide 12 is so telling to the upside if NWBO is successful in gaining approval and then label extensions to other indications including no toxic side effects on thee patient!
Drilla, great find and thanks for sharing! Quite encouraging and very focused plan on Petro Rio's management.
Cannonblack5, I had not seen this interview before but you are dead on with her long term strategy from this interview. I also noted the following on Fraunhofer expansion from this interview. Thanks for sharing this link.
http://www.blackandwhiteprogram.com/interview/northwest-biotherapeutics-inc-nwbo-ob-interview-with-linda-f-powers-ceo
highway....Use Ignore feature it works great!
Sojourner55, keep posting charts they are great source of information and much appreciated!
Sure did hit 1M+ shares traded within first hour PPS up 20%....that was quick!
Do we break 1M shares traded in first hour and now hit $.64??? something brewing??
210k shares of NWBO traded in last 10 minutes and price jumped from $.5849 to $.62...hmmmmmm????
Cancer-stricken 4-year-old girl who touched many in UK dies
Associated Press Associated Press:November 21, 2016
https://www.yahoo.com/news/cancer-stricken-4-old-girl-touched-many-uk-111532134.html?ref=gs
LONDON (AP) — The father of a four-year-old girl whose struggle with a rare form of cancer drew widespread sympathy in Britain has announced that she has died.
Andrew Whelan said on Facebook on Sunday that his daughter Jessica had died that morning.
He said he felt "both sadness and relief in informing you all that Jessica finally found peace," adding that her suffering had ended.
The Lancashire girl's plight had attracted widespread sympathy as her father posted photos of her struggle with neuroblastoma in the months before it took her life. It is a rare form of cancer that primarily hits babies and young children.
He said he was able to have a final "big cuddle" with his daughter before her death. He has been raising money to help fight the disease.
My comment:
This is why you want a company like NWBO and others to be successful in their fight to find a cure for brain cancers. Very sad as she was only 4 years old!
tob999....agree 100% on the manipulation game has been going on for quite a while with NWBO. I am like many longs here that believe DCVax-L Phase III trial will be successful when results are made public.
I posted Jeannine Walston's blog from yesterday highlighting her 3 year survival with DCVax-L for her brain tumor at UCLA under Dr. Liau. She also highlighted many other long term survivors at UCLA from DCVax trials at UCLA. Great to see so many patients surviving from aggressive brain cancer and living normal lives now!
Senti, you really did a great job here! You make some interesting observations that I am sure many overlooked in NWBO PR.
So true RK and thank you for your contributions to this board! You are very much appreciated!
Just out today from Jeannine Waltson and great story with Dr. Liau and DCVax-L! Just outstanding story!
Flip...very much agree with you comment as I remember a conversation with Linda and Les years ago on their European strategy with UK and Germany (multiple shots on goal) and CRC of being one indication that they would target with DCVax. Yesterday's PR is still being digested by the investment community and will be interesting to see trading volume today.
We are getting close to the finish line and possible sprint to the finish line with DCVax-L.
Well said and great points made!
Volume picking up again....approaching 3.5M traded HOD at $.56 and looking to go higher
big surge kicked in about 10:50 and has not stopped. We are already approaching 1.6M traded and broke above $.50.
Volume at 10:50AM EST 353,196 @$.4714
Nice trend going now...
Volume 918,634 $.4838 at 11:24AM EST